Shares of Tilray Brands, Inc. (TLRY) popped in Wednesday's premarket session, riding the wave of a surprisingly profitable quarter. The cannabis and beverage company didn't just beat expectations—it posted record revenue and turned a profit when analysts were bracing for a loss.
The positive move for Tilray came as broader market futures pointed higher, creating a friendlier backdrop for growth-oriented names. But the real story was in the numbers.
The Numbers That Mattered
For the third quarter of its fiscal 2026, Tilray reported adjusted earnings of 2 cents per share. That might not sound like much, but it was a clean beat against the consensus estimate calling for a loss of 14 cents per share. Revenue climbed to a record $206.7 million, also topping the $201.4 million analysts had forecast.
Digging deeper, net revenue was up 11% from the $185.8 million reported a year ago. The growth wasn't uniform, which is often where the interesting stories are. International cannabis net revenue exploded, growing 73% year-over-year. Even more striking, the volume of cannabis flower sold doubled compared to the same period last year.
In its home market of Canada, the combined net revenue from adult-use and medical cannabis increased by a more modest 8%, which the company says reinforces its leadership position there.
On the profitability front, gross profit increased 6% to a record $55.0 million, though the gross margin ticked down slightly to 27% from 28% a year earlier. A key profitability metric, adjusted EBITDA, grew 19% to $10.7 million.
Perhaps most importantly for investors looking for stability, the company reaffirmed its full-year guidance. It still expects fiscal 2026 adjusted EBITDA to land between $62 million and $72 million. That range implies growth of 13% to 31% compared to fiscal 2025.
Beyond Cannabis: The Beverage Bet
Tilray's story isn't just about cannabis anymore. The company highlighted its recent acquisition of craft beer maker BrewDog for roughly 40 million pounds (about $53.27 million). This move is a strategic play to become a bigger player in the global craft beverage scene, giving Tilray enhanced distribution reach across Europe, the Middle East, Australia, Asia-Pacific, and the U.S.
Financially, the company appears to have the dry powder to make more moves. It reported a strong balance sheet with $265 million in cash and marketable securities, which management says provides "ample flexibility for future strategic opportunities."
What the Charts and Analysts Are Saying
The stock's technical picture is sending mixed signals. Shares are trading just 0.8% above their 20-day simple moving average but remain a significant 21.3% below their 100-day average. Over the past year, the stock is down about 1.1% and is currently trading closer to its 52-week lows than its highs.
Momentum indicators are also conflicted. The Relative Strength Index (RSI) sits at 41.24, which is considered neutral. However, the Moving Average Convergence Divergence (MACD) indicator is in negative territory and below its signal line, which technical analysts often interpret as bearish pressure.
The analyst community seems equally divided. The consensus rating on the stock is a Hold. Recent actions include TD Cowen maintaining a Buy rating but lowering its price target to $7.00 in late March, and Roth Capital keeping a Neutral rating while cutting its target to $10.00 back in January.
Looking ahead, the company's next scheduled financial update is estimated for July 27, 2026. For that period, analysts are currently forecasting earnings of 25 cents per share on revenue of $240.63 million, up from prior estimates.
The ETF Angle
For ETF investors, Tilray is a name to watch due to its heavy weighting in certain funds. Most notably, it makes up 15.49% of the Amplify Alternative Harvest ETF (MJ). This significant exposure means that large inflows or outflows for this ETF can trigger automatic, mechanical buying or selling of Tilray shares, adding another layer to its price dynamics.
The Bottom Line: Tilray delivered a quarter that checked all the right boxes: record sales, a surprise profit, and reaffirmed guidance. The 6.06% premarket jump to $6.86 reflects that. Yet, the path forward seems less clear, caught between strong operational growth and a stock that technicals and analysts view with caution. For now, the company is giving investors solid results to chew on.